SynthesisJournal of experimental & clinical cancer research : CR2011

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials.

Federica Cuppone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.